IL-33 and Its Receptor ST2 after Inhaled Allergen Challenge in Allergic Asthmatics-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

IL-33 and Its Receptor ST2 after Inhaled Allergen Challenge in Allergic Asthmatics

Published:2018 Issue:2 Volume:176 Page:133-142
ISSN:1018-2438
Container-title:International Archives of Allergy and Immunology
language:en
Short-container-title:Int Arch Allergy Immunol

Author:

Mitchell Patrick D.,Salter Brittany M.,Oliveria John Paul,El-Gammal Amani,Tworek Damian,Smith Steve G.,Sehmi Roma,Gauvreau Gail M.,O'Byrne Paul M.

Publisher

S. Karger AG

Subject

Immunology,General Medicine,Immunology and Allergy

Reference41 articles.

1. Lloyd CM: IL-33 family members and asth ma – bridging innate and adaptive immune responses. Curr Opin Immunol 2010; 22: 800–806.

2. Moussion C, Ortega N, Girard JP: The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel “alarmin?” PLoS One 2008; 3:e3331.

3. Moulin D, Donze O, Talabot-Ayer D, Mezin F, Palmer G, Gabay C: Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells. Cytokine 2007; 40: 216–225.

4. Kurokawa M, Matsukura S, Kawaguchi M, Ieki K, Suzuki S, Odaka M, et al: Expression and effects of IL-33 and ST2 in allergic bronchial asthma: IL-33 induces eotaxin production in lung fibroblasts. Int Arch Allergy Immunol 2011; 155(suppl 1): 12–20.

5. Palmer G, Lipsky BP, Smithgall MD, Meininger D, Siu S, Talabot-Ayer D, et al: The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33. Cytokine 2008; 42: 358–364.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunological factors, important players in the development of asthma;BMC Immunology;2024-07-26

2. Airborne indoor allergen serine proteases and their contribution to sensitisation and activation of innate immunity in allergic airway disease;European Respiratory Review;2024-04-24

3. Tezepelumab: patient selection and place in therapy in severe asthma;Journal of International Medical Research;2024-04

4. Advances in Diagnosis and Treatment of Difficult-to-Treat/Severe Asthma in Children;Advances in Clinical Medicine;2024

5. Undaria pinnatifida extract attenuates allergic airway inflammation by the modulation of epithelial cell dysfunction and oxidative stress;2023-12-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3